4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-004542
Options or other derivatives
- CHIEF LEGAL OFFICER acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Adler Reid G. CHIEF LEGAL OFFICER | 2022-05-02 | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | D | ||
Loading xslF345X03/form4-05032022_020513.xml…